Search results for "Hazard"

showing 10 items of 1517 documents

Social deprivation and 1‐year survival after stroke: a prospective cohort study

2020

BACKGROUND Social deprivation may have a deleterious influence on post-stroke outcomes, but available data in the literature are mixed. AIM The aim of this cohort study was to evaluate the impact of social deprivation on 1-year survival in patients with first-ever stroke. METHODS Social deprivation was assessed at individual level with the EPICES score, a validated multidimensional questionnaire, in 1312 patients with ischemic stroke and 228 patients with spontaneous intracerebral hemorrhage, who were prospectively enrolled in six French study centers. Baseline characteristics including stroke severity and pre-stroke functional status were collected. Multivariable Cox models were generated …

medicine.medical_specialtyInfarctionCohort Studies03 medical and health sciences0302 clinical medicineInternal medicineHumansMedicineProspective Studies030212 general & internal medicineProspective cohort studyStrokeCerebral HemorrhageIntracerebral hemorrhagebusiness.industryProportional hazards modelHazard ratiomedicine.diseaseStrokeSocial deprivationSocioeconomic FactorsNeurologyNeurology (clinical)business030217 neurology & neurosurgeryCohort studyEuropean Journal of Neurology
researchProduct

Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction

2019

Aim: To evaluate the long-term outcome of patients with Takotsubo syndrome (TTS) and severely reduced left ventricular ejection fraction (LVEF ≤ 35%) at presentation. Methods and results: The study population included 326 patients (mean age 69.5 ± 10.7 years, 28 male) with TTS enrolled in the Takotsubo Italian Network, divided into two groups according to LVEF (≤ 35%, n = 131; > 35%, n = 195), as assessed by transthoracic echocardiography at hospital admission. In-hospital events were recorded in both groups. At long-term follow-up (median 26.5 months, interquartile range 18–33), composite major adverse cardiac events (MACE: cardiac death, acute myocardial infarction, heart failure, and …

medicine.medical_specialtyLeft ventricular ejection fractionCardiomyopathyHeart failure030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicinemedicinecardiovascular diseasesMyocardial infarctionCardiogenic shock; Cardiomyopathy; Heart failure; Left ventricular ejection fraction; Takotsubo syndromeCardiogenic shockEjection fractionbusiness.industryCardiogenic shockHazard ratiomedicine.diseaseConfidence intervalHeart failureCardiologybusinessTakotsubo syndromeCardiology and Cardiovascular MedicineCardiogenic shock; Cardiomyopathy; Heart failure; Left ventricular ejection fraction; Takotsubo syndrome; Cardiology and Cardiovascular MedicineMace
researchProduct

Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, ra…

2021

International audience; BACKGROUND: Delaying renal replacement therapy (RRT) for some time in critically ill patients with severe acute kidney injury and no severe complication is safe and allows optimisation of the use of medical devices. Major uncertainty remains concerning the duration for which RRT can be postponed without risk. Our aim was to test the hypothesis that a more-delayed initiation strategy would result in more RRT-free days, compared with a delayed strategy. METHODS: This was an unmasked, multicentre, prospective, open-label, randomised, controlled trial done in 39 intensive care units in France. We monitored critically ill patients with severe acute kidney injury (defined …

medicine.medical_specialtyMESH: Acute Kidney Injury[SDV]Life Sciences [q-bio]medicine.medical_treatmentPopulation030204 cardiovascular system & hematologyurologic and male genital diseasesMESH: Severity of Illnes Index03 medical and health sciencesMESH: Aged 80 and over0302 clinical medicineOliguriaIntensive careInternal medicineMedicineMESH: Time-to-Treatment030212 general & internal medicineRenal replacement therapyeducationBlood urea nitrogenMESH: Agededucation.field_of_studyMESH: HumansMESH: Middle Agedbusiness.industryHazard ratioAcute kidney injuryGeneral Medicinemedicine.diseaseMESH: MaleMESH: Prospective Studies3. Good health[SDV] Life Sciences [q-bio]MESH: FranceMESH: Intensive Care Unitsmedicine.symptomMESH: Renal Remplacement TherapybusinessMESH: FemaleKidney diseaseThe Lancet
researchProduct

Knowledge and awareness regarding biomedical waste management in dental teaching institutions in India- A systematic review.

2014

Objectives: Proper handling, treatment and disposal of biomedical wastes are important elements in any health care setting. Not much attention has been paid to the management of Biomedical Waste (BMW) in recent years, in dental colleges and hospitals in India. The present systematic review was conducted to assess knowledge and awareness regarding BMW management among staff and students of dental teaching institutions in India. Material and Methods: A systematic review of relevant cross-sectional studies was conducted regarding BMW management in India in dental teaching institutions in India. Six studies were finally included in the present review after conducting both electronic and manual …

medicine.medical_specialtyMedical educationbusiness.industryAwareness levelAlternative medicineMEDLINEBiomedical wasteLegislatureOdontologíaReview:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludCommunity and Preventive DentistryHealth care wasteHazardous wasteHealth careUNESCO::CIENCIAS MÉDICASmedicinebusinessGeneral DentistryJournal of clinical and experimental dentistry
researchProduct

Mediterranean diet and antihypertensive drug use: a randomized controlled trial

2021

Objective To examine in older individuals at high cardiovascular risk whether following a Mediterranean diet decreased the necessity of antihypertensive drugs and modulated their associated cardiovascular risk. Methods In the PREvencion con DIeta MEDiterranea study, we assessed whether volunteers randomly allocated to an intervention with a Mediterranean diet enriched with extra-virgin olive oil or nuts (relative to a low-fat control diet) disclosed differences in the risk of: initiating antihypertensive medication in nonusers at baseline (n = 2188); and escalating therapy in participants using one, two, or three drugs at baseline (n = 2361, n = 1579, and n = 554, respectively). We also ass…

medicine.medical_specialtyMediterranean dietPhysiologymedicine.drug_classPsychological intervention030204 cardiovascular system & hematologyDiet MediterraneanLower risklaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRisk FactorslawInternal medicineInternal MedicinemedicineHumansNuts030212 general & internal medicineAntihypertensive drugOlive OilAntihypertensive AgentsAgedbusiness.industryIncidence (epidemiology)Hazard ratioCardiovascular DiseasesCardiology and Cardiovascular MedicinebusinessOlive oilJournal of Hypertension
researchProduct

Mediterranean Diet and Invasive Breast Cancer Risk Among Women at High Cardiovascular Risk in the PREDIMED Trial

2015

Importance Breast cancer is the leading cause of female cancer burden, and its incidence has increased by more than 20% worldwide since 2008. Some observational studies have suggested that the Mediterranean diet may reduce the risk of breast cancer. Objective To evaluate the effect of 2 interventions with Mediterranean diet vs the advice to follow a low-fat diet (control) on breast cancer incidence. Design, Setting, and Participants The PREDIMED study is a 1:1:1 randomized, single-blind, controlled field trial conducted at primary health care centers in Spain. From 2003 to 2009, 4282 women aged 60 to 80 years and at high cardiovascular disease risk were recruited after invitation by their p…

medicine.medical_specialtyMediterranean dietSistema cardiovascular -- MalaltiesDonesCàncer de mamalaw.inventionMedicina preventivaClinical trialsMediterranean cookingBreast cancerBreast cancerDiet and cancerBreast Cancer Prevention TrialRandomized controlled triallawInternal medicineCuina mediterràniaInternal MedicinemedicineWomenDieta -- Mediterrània Regió de laPreventive medicinebusiness.industryIncidence (epidemiology)Hazard ratiomedicine.diseaseSurgeryMama -- CàncerObservational studybusinessAssaigs clínicsJAMA Internal Medicine
researchProduct

The Mediterranean diet, plasma metabolome, and cardiovascular disease risk.

2020

Abstract Aims To investigate whether metabolic signature composed of multiple plasma metabolites can be used to characterize adherence and metabolic response to the Mediterranean diet and whether such a metabolic signature is associated with cardiovascular disease (CVD) risk. Methods and results Our primary study cohort included 1859 participants from the Spanish PREDIMED trial, and validation cohorts included 6868 participants from the US Nurses’ Health Studies I and II, and Health Professionals Follow-up Study (NHS/HPFS). Adherence to the Mediterranean diet was assessed using a validated Mediterranean Diet Adherence Screener (MEDAS), and plasma metabolome was profiled by liquid chromatogr…

medicine.medical_specialtyMediterranean dietbusiness.industryIncidence (epidemiology)Hazard ratioDiseaseOdds ratio030204 cardiovascular system & hematologyDiet Mediterranean03 medical and health sciences0302 clinical medicineCardiovascular DiseasesRisk FactorsInternal medicineCohortMendelian randomizationMetabolomemedicineMetabolomeHumans030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesGenome-Wide Association StudyEuropean heart journal
researchProduct

Compliance with patient-reported outcome assessment in glioma patients: predictors for drop out

2017

Abstract Background Patient-reported outcomes are of high importance in clinical neuro-oncology. However, assessment is still suboptimal. We aimed at exploring factors associated with the probability for a) drop out of study and b) death during follow-up. Methods Patients were assessed twice during follow-up visits scheduled within 3 to 5 months of each other by using 3 validated patient-reported outcome measures (t1: first assessment, t2: second assessment). As “death” was seen as a competing risk for drop out, univariate competing risk Cox regression models were applied to explore factors associated with dropping out (age, gender, WHO grade, living situation, recurrent surgery, Karnofsky …

medicine.medical_specialtyMotor dysfunctionKarnofsky Performance Statusbusiness.industryProportional hazards modelMedicine (miscellaneous)Original Articlesmedicine.diseasehumanities03 medical and health sciences0302 clinical medicinePhysical functioning030220 oncology & carcinogenesisDrop outInternal medicineGliomamedicinePhysical therapyDistress ThermometerPatient-reported outcomebusiness030217 neurology & neurosurgeryNeuro-Oncology Practice
researchProduct

2021

IntroductionWork-life conflicts (WLC) may impact health, but few studies prospectively consider the impact of WLC on objective outcomes such as cardiovascular disease. Using data from the Gutenberg Health Study (GHS), we examined if WLC at baseline was associated with an increased five-year incidence of cardiovascular events (myocardial infarct, stroke, atrial fibrillation, peripheral artery disease, coronary artery disease, chronic heart failure, sudden cardiac death). We also considered if WLC was associated with incident hypertension and arterial stiffness and if the effects of WLC on cardiovascular health differ for men and women.MethodsA working subsample of the 15,010 GHS cohort parti…

medicine.medical_specialtyMultidisciplinaryProportional hazards modelbusiness.industryHazard ratiomedicine.diseaseCoronary artery diseasesymbols.namesakeBlood pressureRelative riskInternal medicineCohortArterial stiffnessmedicinesymbolsPoisson regressionbusinessPLOS ONE
researchProduct

Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19

2021

Key Points Three-day change in angiopoietin-2 levels predicts COVID-19 in-hospital mortality, whereas the 10-day trend is associated with chronic lung disability. Angiopoietin-2 may play an important pathogenic role in patients with COVID-19, and it could be a target for new treatments.

medicine.medical_specialtyMultivariate analysis20CD34Risk Factors ...030204 cardiovascular system & hematologyGastroenterologyAntiviral AgentsAngiopoietin-203 medical and health sciences0302 clinical medicineRisk FactorsVascular BiologyInternal medicinemedicineHumans030212 general & internal medicineHospital MortalitySurvival rateProportional Hazards ModelsAntiviral AgentLungReceiver operating characteristicbusiness.industryProportional hazards modelSARS-CoV-2Interleukin-6Risk FactorHazard ratioCOVID-19HematologyBiomarker32Confidence intervalCOVID-19 Drug TreatmentHospitalizationSurvival RateAngiopoietin-2; Antiviral Agents; Area Under Curve; Biomarkers; COVID-19; Hospital Mortality; Hospitalization; Humans; Interleukin-6; Proportional Hazards Models; ROC Curve; Risk Factors; SARS-CoV-2; Survival Ratemedicine.anatomical_structureROC CurveArea Under Curvecardiovascular systemProportional Hazards ModelbusinessBiomarkersHuman
researchProduct